Literature DB >> 3987208

Factors affecting the 'alveolar deposition' of 5 microns inhaled particles in healthy subjects.

J E Agnew, D Pavia, S W Clarke.   

Abstract

The long-term lung retention fraction of insoluble inhaled aerosols--'alveolar deposition' (AD)--may be assessed in healthy subjects from lung retention at 24 h. For persons inhaling long-lived hazardous particles this represents their long-term dose commitment; in clinical tests of mucociliary function with inert particles it represents the fraction of particles not available to act as tracers of mucus transport. AD (24 h retention) was measured with 99Tcm-labelled, 5 microns diameter polystyrene particles which were inhaled at various flow rates; a post-inspiratory breath-hold of 3 s maximised AD efficiency. In 32 tests on young non-smokers (age less than or equal to 30 y), AD was significantly related to flow rate (r = 0.61, p less than 0.001). Intersubject variability about the regression line was not related to variability of airway calibre as detected by conventional spirometry. Significant dependence of AD on flow rate but not lung function was found in young asymptomatic cigarette smokers and in older non-smokers. In older smokers (age greater than 30 y) dependence on flow rate was significant but dependence on lung function equivocal. Smoking was associated with decreased AD. A considerable intersubject variability of AD could not be attributed to variability of inhalation conditions or lung function. AD should therefore be directly measured whenever possible in occupational hygiene assessments and clinical aerosol applications.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3987208     DOI: 10.1088/0143-0815/6/1/003

Source DB:  PubMed          Journal:  Clin Phys Physiol Meas        ISSN: 0143-0815


  4 in total

1.  Inhaled insulin: take a deep breath, but how?

Authors:  Lutz Heinemann; Gerhard Scheuch; Tim Heise
Journal:  J Diabetes Sci Technol       Date:  2008-03

2.  A rapid method for the evaluation of diagnostic radioaerosol delivery systems.

Authors:  P Phipps; P Borham; I Gonda; D Bailey; G Bautovich; S Anderson
Journal:  Eur J Nucl Med       Date:  1987

3.  Airspace Dimension Assessment with Nanoparticles (AiDA) in Comparison to Established Pulmonary Function Tests.

Authors:  Madeleine Petersson-Sjögren; Jonas Jakobsson; H Laura Aaltonen; Hanna Nicklasson; Jenny Rissler; Gunnar Engström; Per Wollmer; Jakob Löndahl
Journal:  Int J Nanomedicine       Date:  2022-06-25

4.  Sodium pertechnetate (Na99mTcO4) biodistribution in mice exposed to cigarette smoke.

Authors:  Samuel S Valenca; Elaine Ac Lima; Gláucio F Dire; Mário Bernardo-Filho; Luís Cristóvão Porto
Journal:  BMC Nucl Med       Date:  2005-04-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.